ALFA Filings
Every announcement, straight from the exchange
Every fund raise announcement on NSE and BSE that our alert engine sent, newest first.
Time
2,009 announcements
Concord Control Systems reported zero deviation in utilizing ₹50.09 Crore raised via preferential issue. The Audit Committee confirmed the company has now completely utilized these funds.
Shelter Pharma reported zero deviation in utilizing ₹25.31 Crore raised via preferential warrant issues. Funds were fully deployed toward working capital requirements as approved.
Abha Power and Steel Limited reported full utilization of ₹26.84 Crore raised through its IPO. No deviations or variations in fund deployment were noted.
Aakaar Medical Technologies reported zero deviation in utilizing its ₹27 Crore IPO proceeds. The filing confirms funds were deployed according to the stated prospectus objects.
Uday Jewellery Industries confirmed zero deviation in utilizing ₹29.45 Crore raised via preferential issue. Funds were fully deployed toward working capital requirements as intended.
Lords Chloro Alkali Limited reported zero deviation in utilizing ₹32.02 Crore raised through warrant conversions. Funds were deployed for capital expenditure, working capital, and general corporate purposes.
Jainex Aamcol Limited reported the utilization of its ₹8.98 Crore Rights Issue proceeds. The Audit Committee confirmed no deviations or variations in fund usage.
Globtier Infotech Limited confirmed full utilization of its ₹27.44 Crore IPO proceeds. The statutory auditor certified that funds were deployed as per offer document objectives.
Clinitech Laboratory Ltd reported zero deviation in the utilization of INR 578.30 Lakhs raised through its IPO. Funds were deployed primarily for diagnostic center expansion.
Micropro Software Solutions Limited reported zero deviation in utilizing its ₹30.70 Crore IPO proceeds. The funds were deployed for working capital, capital expenditure, and corporate expenses.
Hindprakash Industries Limited confirmed the full utilization of ₹6.15 Crore raised through convertible warrants. The Audit Committee reported no deviations or variations in fund usage.
Ashika Credit Capital allotted 4.03 Crore shares following its merger with Ashika Global Securities. This restructuring consolidates operations and changes the company's capital structure.
Midwest Limited reported zero deviation in utilizing its ₹201 Crore IPO proceeds for the March 2026 quarter. This confirms funds are being deployed per stated objectives.
Rishi Laser Limited reported zero deviation in the utilization of ₹12 Crore raised via preferential issues. The funds are being deployed for expansion and working capital.
Agarwal Toughened Glass India Limited submitted its IPO fund utilization certificate for the 2025-2026 fiscal year. The report confirms utilization of Rs. 62.64 Crore proceeds.
Ganesh Benzoplast confirmed full utilization of ₹62.75 Crore raised through preferential issues with zero deviation. This regulatory clearance validates the company's transparent capital deployment strategy.
Rachit Prints Ltd confirmed zero deviation in utilizing Rs.18.01 Crore IPO proceeds. About Rs.4.40 Crore remains unutilized and temporarily deployed in fixed deposits.
Aveer Foods Limited confirmed full utilization of ₹26 Crore raised via preferential issue. Funds were deployed for business acquisition and working capital with no deviations.
Halder Venture Ltd submitted a revised valuation report for its proposed preferential issue of 7,93,650 warrants. The updated valuation stands at Rs. 315 per share.
Man Industries (India) Ltd confirmed zero deviation in the utilization of ₹264.99 Crore raised via preferential issues. Funds were deployed for working capital and corporate purposes.
My Mudra Fincorp reported nil deviation in utilizing Rs. 33.26 Crore raised via its IPO. The company confirmed full alignment with stated objects for FY2026.
Sathlokhar Synergys E&C Global reported utilizing ₹93.24 Crore from its preferential issue proceeds. There were no deviations or variations in the utilization of funds.
Aplab Limited confirmed the full utilization of ₹6.29 Crore raised through its Rights Issue. Infomerics Ratings certified that proceeds were deployed toward specified issue objects.
Camex Limited reported nil deviation in the utilization of funds raised through its IPO for the March 2026 quarter. The filing confirms regulatory compliance.
Piccadily Agro Industries reported zero deviation in utilizing ₹261.99 Crore raised via preferential issue. Funds are deployed across business expansion, working capital, and corporate purposes.
Medicamen Biotech Limited reported zero deviation in the utilization of ₹53.57 Crore raised via preferential issue. The funds are being deployed for drug development and expansion.
Shyama Computronics and Services reported zero deviations in the utilization of preferential issue proceeds for the March 2026 quarter. No funds were raised during this period.
Patel Chem Specialities confirmed zero deviation in utilizing ₹58.80 Crore IPO proceeds. Funds were deployed for Capex and corporate purposes, with ₹36.24 Crore remaining in deposits.
BlackBuck Limited reported no deviation in utilization of ₹550.00 Crore IPO proceeds for the March 2026 quarter. The Audit Committee reviewed and approved the statement.
Sat Kartar Life allotted 26,95,200 convertible warrants at ₹172 each via preferential issue, raising ₹46.36 Crore. The company received 25% upfront subscription money from fourteen investors.